Nchi: Australia
Lugha: Kiingereza
Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)
FELINE CALICIVIRUS; LIVE FELINE HERPES VIRUS
INTERVET AUSTRALIA PTY LIMITED
feline calicivirus+feline rhinotracheitis
MISC. VACCINES OR ANTI SERA
FELINE CALICIVIRUS VACCINE-VIRAL Active 4.6 PFU/dose; LIVE FELINE HERPES VIRUS VACCINE-VIRAL Active 4.8 PFU/dose
10 x single dose vial; 20 x single dose vials; 25 x single dose vial; 50 x single dose vial
VM - Veterinary Medicine
INTERVET AUSTRALIA
CAT | CAT - QUEEN | CAT - TOM | KITTEN
IMMUNOTHERAPY
FELINE CALICIVIRUS | FELINE RHINOTRACHEITIS | CALICIVIRUS (FELINE) | FCV | FELINE HERPESVIRUS TYPE 1 | FHV-1 | FVR | HERPESVIRUS 1 (FELINE) | HERPESVIRUS TYPE 1 (FELINE) | RHINOTRACHEITIS (FELINE)
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [FELINE CALICIVIRUS, FELINE RHINOTRACHEITIS]; Live vaccine for the active immunisation of cats to reduce the clinical signs caused by infection with feline calicivirus & feline herpes virus type 1.The safety of this product has not been tested in pregnant or lactating queens. See also SIDE EFFECTS & MANDATORY WARNINGS on lealet.
Registered
2023-07-01
Product Name: APVMA Approval No: NOBIVAC DUCAT 62997/133638 Label Name: NOBIVAC DUCAT Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: Each single dose contains at least: 4.6 log ^ 10 PFU 1 of live feline calicivirus F9 strain and 4.8 log ^ 10 PFU 1 of live feline herpes virus type 1 G2620A strain. 1 PFU: Plaque-Forming Units Claims: Live vaccine for the active immunisation of cats to reduce the clinical signs caused by infection with feline calicivirus and feline herpes virus type 1. Net Contents: 10 x single dose vials (1 mL after reconstitution). 20 x single dose vials (1 mL after reconstitution). 25 x single dose vials (1 mL after reconstitution). 50 x single dose vials (1 mL after reconstitution). Directions for Use: Restraints: Contraindications: Precautions: The safety of these products this product has not been tested in pregnant or lactating queens. Only healthy cats should be vaccinated and an adequate clinical examination should be made prior to inoculation. Sterile equipment should be used for administration, but avoid contamination of vaccine with traces of disinfectant or spirit. RLP APPROVED Side Effects: A slight, painful swelling may be observed at the injection site for 1-2 days. A slight transient rise in temperature (up to 40°C) may occur for 1-2 days. In some cases, general discomfort, coughing, sneezing, transient lethargy and reduced appetite may be observed for a few days post-vaccination. Dosage and Administration: USE ALL PRODUCT WITHIN 30 MINUTES OF RECONSTITUTION The contents of one vial of reconstituted vaccine should be injected subcutaneously. Reconstitute immediately prior to use by the addition of 1.0 mL of sterile phosphate buffer or Water for Injection. Primary vaccination Vaccination may commence from 8-9 weeks of age. Kittens and cats should receive two vaccinations with an interval of 3-4 weeks. The final vaccination of the kitten course should be administered from 12 weeks of age onwards. Revaccinati Soma hati kamili